EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The still incomplete pursuit of universal access to medicines

Paloma Fernández iD, Alicia Del Llano, Jaume Vidal, Jaime Espín, Juan E Del Llano

Health Economics, Policy and Law · 2025-07 · 20 (3) · 284-296

DOI: 10.1017/s1744133125000040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Economics, Policy and Law, online erschienen am 22.05.2025. Verfasst von Paloma Fernández und 4 weiteren Autor:innen. Beteiligte Einrichtung: Independent Scholar. Hauptthemen laut MEDLINE: Health Services Accessibility, Drug Industry, Drugs, Essential. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A substantial share of the global population continues to face barriers to accessing essential medicines. While the pharmaceutical industry’s business model has successfully facilitated the development of innovative medications, efforts to promote universal access to medicines (UAM) remain ineffective. This paper critically assesses the existing barriers to global access to medicines, including the role of unsuitable governance, the protection of intellectual property rights, and other market barriers such as shortages, quality shortcomings, and high prices. Furthermore, we explore a number of promising potential strategies that can help towards achieving the UAM. Specifically, we evaluate the evidence from various initiatives, including alternative models of innovation, manufacturing, procurement, intellectual property management, and structural/organisational operations. We argue that the effective realisation of UAM requires a robust framework to implement these initiatives. This framework must strike a delicate balance between addressing public health needs, incentivising research and development, and ensuring affordability. Achieving such a balance encompasses a careful oversight and collaboration between national and international regulatory bodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health Services AccessibilityDrug IndustryDrugs, EssentialHumansGlobal HealthIntellectual Property

Stichwörter der Autor:innen

access to medicinesglobalisationinequality and healthintellectual propertypharmaceutical industrystakeholder effects

Substanzen

Drugs, Essential

Autor:innen und Institutionen

  • Independent Scholar.
  • Gaspar Casal Foundation, Madrid, Spain.
  • Health Action International (HAI), Amsterdam, Netherlands.
  • Andalusian School of Public Health (EASP), Granada, Spain.
  • CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Instituto de Investigación Biosanitaria IBS, Granada, Spain.

ORCID-Profile: Paloma Fernández

Zitieren

APA

Fernández, P., Del Llano, A., Vidal, J., Espín, J., & Del Llano, J. E. (2025). The still incomplete pursuit of universal access to medicines. Health Economics, Policy and Law, 20(3), 284-296. https://doi.org/10.1017/s1744133125000040

Vancouver

Fernández P, Del Llano A, Vidal J, Espín J, Del Llano JE. The still incomplete pursuit of universal access to medicines. Health Economics, Policy and Law. 2025;20(3):284-296. doi:10.1017/s1744133125000040

BibTeX
@article{Fernndez2025,
  author = {Fernández, Paloma and Del Llano, Alicia and Vidal, Jaume and Espín, Jaime and Del Llano, Juan E},
  title = {The still incomplete pursuit of universal access to medicines},
  journal = {Health Economics, Policy and Law},
  year = {2025},
  volume = {20},
  number = {3},
  pages = {284--296},
  doi = {10.1017/s1744133125000040}
}
Kostenlos starten →